« FDA Approvals - Wyeth Receives Approvable Letter From FDA For TYGACIL For The | Main | FDA Approvals - Lupin gets tentative approval from FDA (Business Standard India) Pharmaceutical »

Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal


Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers (Presseportal)
Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the Company's investigational 13-valent ...

Pollution Firms Roll Despite Weak Growth (Investor's Business Daily via Yahoo! News)
There are a couple of reasons to assume waste collection and management stocks wouldn't be doing so well right now.

Tainted Drug Imports Set Off Warnings, Not FDA Action (Bloomberg via Yahoo! News)
May 30 (Bloomberg) -- Two Americans died and 15 suffered seizures. The suspected cause: The epilepsy medicine they depended on stopped working because of a counterfeit ingredient from overseas.
 

©2006 FDA-News.com. All rights reserved.